{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:58:03Z","timestamp":1784872683212,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Ethics Committee of Inner Mongolia People\u2019s Hospital","award":["202400901L"],"award-info":[{"award-number":["202400901L"]}]},{"name":"Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["2023GLLH0012, 2023GLLH0038"],"award-info":[{"award-number":["2023GLLH0012, 2023GLLH0038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-05006-5","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:42:47Z","timestamp":1760935367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary investigation of the association between desmoglein-2 expression and patient prognosis following radical surgery for colon cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Yanqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"1","key":"5006_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Ca-Cancer J Clin 73(1):17\u201348","journal-title":"Ca-Cancer J Clin"},{"issue":"3","key":"5006_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin 71(3):209\u2013249","journal-title":"Ca-Cancer J Clin"},{"issue":"6","key":"5006_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7555\/JBR.28.20140079","volume":"28","author":"CS Yang","year":"2014","unstructured":"Yang CS, Feng Q (2014) Chemo\/dietary prevention of cancer: perspectives in China. J Biomed Res 28(6):447\u2013455","journal-title":"J Biomed Res"},{"key":"5006_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783362","volume":"12","author":"Z Wu","year":"2021","unstructured":"Wu Z, Lu Z, Li L, Ma M, Long F, Wu R, Huang L, Chou J, Yang K, Zhang Y et al (2021) Identification and validation of ferroptosis-related LncRNA signatures as a novel prognostic model for colon cancer. Front Immunol 12:783362","journal-title":"Front Immunol"},{"key":"5006_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1479-5876-10-220","volume":"10","author":"X Wang","year":"2012","unstructured":"Wang X, Ward PA (2012) Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine. J Transl Med 10:220","journal-title":"J Transl Med"},{"issue":"2","key":"5006_CR6","first-page":"317","volume":"18","author":"N Nishioka","year":"2001","unstructured":"Nishioka N, Yashiro M, Inoue T, Matsuoka T, Ohira M, Chung KH (2001) A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2. Int J Oncol 18(2):317\u2013322","journal-title":"Int J Oncol"},{"key":"5006_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.forsciint.2019.06.008","volume":"301","author":"Y Zou","year":"2019","unstructured":"Zou Y, Zhang Q, Zhang J, Chen X, Zhou W, Yang Z, Yang Q, Yu H, Li L, He Y et al (2019) A common indel polymorphism of the Desmoglein-2 (DSG2) is associated with sudden cardiac death in Chinese populations. Forensic Sci Int 301:382\u2013387","journal-title":"Forensic Sci Int"},{"issue":"1","key":"5006_CR8","doi-asserted-by":"publisher","first-page":"21687","DOI":"10.1038\/s41598-021-00996-y","volume":"11","author":"H Moazzen","year":"2021","unstructured":"Moazzen H, Venger K, Kant S, Leube RE, Krusche CA (2021) Desmoglein 2 regulates cardiogenesis by restricting hematopoiesis in the developing murine heart. Sci Rep-Uk 11(1):21687","journal-title":"Sci Rep-Uk"},{"key":"5006_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0074-7696(07)64003-0","volume":"264","author":"B Holthofer","year":"2007","unstructured":"Holthofer B, Windoffer R, Troyanovsky S, Leube RE (2007) Structure and function of desmosomes. Int Rev Cytol 264:65\u2013163","journal-title":"Int Rev Cytol"},{"key":"5006_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1327478","volume":"13","author":"MK Myo","year":"2023","unstructured":"Myo MK, Ffrench CB, McClure BJ, Ortiz M, Dorward EL, Samuel MS, Ebert LM, Mahoney MG, Bonder CS (2023) Desmoglein-2 as a cancer modulator: friend or foe? Front Oncol 13:1327478","journal-title":"Front Oncol"},{"issue":"12","key":"5006_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1080\/15384047.2020.1843323","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Beidler P, Wang H, Li C, Quassab A, Coles C, Drescher C, Carter D, Lieber A (2020) Desmoglein-2 as a prognostic and biomarker in ovarian cancer. Cancer Biol Ther 21(12):1154\u20131162","journal-title":"Cancer Biol Ther"},{"key":"5006_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014408118","author":"PH Chang","year":"2021","unstructured":"Chang PH, Chen MC, Tsai YP, Tan G, Hsu PH, Jeng YM, Tsai YF, Yang MH, Hwang-Verslues WW (2021) Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2014408118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5006_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00432-016-2250-0","volume":"143","author":"F Cai","year":"2017","unstructured":"Cai F, Zhu Q, Miao Y, Shen S, Su X, Shi Y (2017) Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin 143(1):59\u201369","journal-title":"J Cancer Res Clin"},{"key":"5006_CR14","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8420","volume":"8","author":"R Sun","year":"2020","unstructured":"Sun R, Ma C, Wang W, Yang S (2020) Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods. PeerJ 8:e8420","journal-title":"PeerJ"},{"key":"5006_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2020.04.001","volume":"483","author":"R Jin","year":"2020","unstructured":"Jin R, Wang X, Zang R, Liu C, Zheng S, Li H, Sun N, He J (2020) Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR\/Src\/PAK1 pathway in lung adenocarcinoma. Cancer Lett 483:46\u201358","journal-title":"Cancer Lett"},{"issue":"17","key":"5006_CR16","first-page":"5481","volume":"22","author":"CP Han","year":"2018","unstructured":"Han CP, Yu YH, Wang AG, Tian Y, Zhang HT, Zheng ZM, Liu YS (2018) Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients. Eur Rev Med Pharmaco 22(17):5481\u20135489","journal-title":"Eur Rev Med Pharmaco"},{"issue":"3","key":"5006_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41418-020-00628-4","volume":"28","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kim JM, Lee DG, Lee J, Park JG, Han TS, Cho HS, Cho YL, Bae KH, Park YJ et al (2021) Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation. Cell Death Differ 28(3):968\u2013984","journal-title":"Cell Death Differ"},{"issue":"8","key":"5006_CR18","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/mc.22644","volume":"56","author":"K Hutz","year":"2017","unstructured":"Hutz K, Zeiler J, Sachs L, Ormanns S, Spindler V (2017) Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells. Mol Carcinog 56(8):1884\u20131895","journal-title":"Mol Carcinog"},{"issue":"5","key":"5006_CR19","first-page":"G478","volume":"313","author":"Y Liu","year":"2017","unstructured":"Liu Y, Chidgey M, Yang VW, Bialkowska AB (2017) Kruppel-like factor 5 is essential for maintenance of barrier function in mouse colon. Am J Physiol-Gastr L 313(5):G478\u2013G491","journal-title":"Am J Physiol-Gastr L"},{"issue":"9","key":"5006_CR20","volume":"9","author":"WA Bye","year":"2017","unstructured":"Bye WA, Nguyen TM, Parker CE, Jairath V, East JE (2017) Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev 9(9):D279","journal-title":"Cochrane Database Syst Rev"},{"key":"5006_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"5006_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A et al (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39(4):782\u2013795","journal-title":"Immunity"},{"issue":"10","key":"5006_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00595-020-02007-5","volume":"50","author":"R Sato","year":"2020","unstructured":"Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, Tsuchiya H, Akazawa N, Sato M, Ohira T et al (2020) The prognostic value of the prognostic nutritional index and inflammation-based markers in obstructive colorectal cancer. Surg Today 50(10):1272\u20131281","journal-title":"Surg Today"},{"issue":"3","key":"5006_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00595-019-01862-1","volume":"50","author":"R Sato","year":"2020","unstructured":"Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, Tsuchiya H, Akazawa N, Sato M, Ohira T et al (2020) Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer. Surg Today 50(3):232\u2013239","journal-title":"Surg Today"},{"issue":"27","key":"5006_CR25","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA et al (2005) Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. P Natl Acad Sci USA 102(27):9571\u20139576","journal-title":"P Natl Acad Sci USA"},{"issue":"10","key":"5006_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nri.2016.94","volume":"16","author":"H Qi","year":"2016","unstructured":"Qi H (2016) T follicular helper cells in space-time. Nat Rev Immunol 16(10):612\u2013625","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5006_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ni.3054","volume":"16","author":"H Ueno","year":"2015","unstructured":"Ueno H, Banchereau J, Vinuesa CG (2015) Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol 16(2):142\u2013152","journal-title":"Nat Immunol"},{"issue":"7","key":"5006_CR28","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G et al (2013) CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 123(7):2873\u20132892","journal-title":"J Clin Invest"},{"key":"5006_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026062","author":"BJ Aubrey","year":"2016","unstructured":"Aubrey BJ, Strasser A, Kelly GL (2016) Tumor-suppressor functions of the TP53 pathway. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a026062","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"5006_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.18632\/oncotarget.13483","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Sun Q (2017) TP53 mutations, expression and interaction networks in human cancers. Oncotarget 8(1):624\u2013643","journal-title":"Oncotarget"},{"issue":"5","key":"5006_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.tranon.2018.07.012","volume":"11","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Liu Z, Li M, Chen C, Wang X (2018) Immunogenomics analysis reveals that TP53 mutations inhibit tumor immunity in gastric cancer. Transl Oncol 11(5):1171\u20131187","journal-title":"Transl Oncol"},{"key":"5006_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ebiom.2018.05.019","volume":"32","author":"W Xiao","year":"2018","unstructured":"Xiao W, Du N, Huang T, Guo J, Mo X, Yuan T, Chen Y, Ye T, Xu C, Wang W et al (2018) TP53 mutation as potential negative predictor for response of anti-CTLA-4 therapy in metastatic melanoma. EBioMedicine 32:119\u2013124","journal-title":"EBioMedicine"},{"key":"5006_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.csbj.2019.07.009","volume":"17","author":"H Lyu","year":"2019","unstructured":"Lyu H, Li M, Jiang Z, Liu Z, Wang X (2019) Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer. Comput Struct Biotec 17:1020\u20131030","journal-title":"Comput Struct Biotec"},{"key":"5006_CR34","doi-asserted-by":"publisher","first-page":"12326","DOI":"10.1038\/ncomms12326","volume":"7","author":"L Du","year":"2016","unstructured":"Du L, Li YJ, Fakih M, Wiatrek RL, Duldulao M, Chen Z, Chu P, Garcia-Aguilar J, Chen Y (2016) Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun 7:12326","journal-title":"Nat Commun"},{"issue":"50","key":"5006_CR35","doi-asserted-by":"publisher","first-page":"83488","DOI":"10.18632\/oncotarget.13129","volume":"7","author":"LS Yang","year":"2016","unstructured":"Yang LS, Zhang XJ, Xie YY, Sun XJ, Zhao R, Huang QH (2016) SUMOylated MAFB promotes colorectal cancer tumorigenesis. Oncotarget 7(50):83488\u201383501","journal-title":"Oncotarget"},{"issue":"2","key":"5006_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591\u2013605","journal-title":"Cell Death Differ"},{"issue":"12","key":"5006_CR37","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1080\/15548627.2021.1912270","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, Yang KB, Chen W, Mai J, Wu XQ, Sun T, Wu RY, Jiao L, Li DD, Ji J et al (2021) CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy 17(12):4323\u20134340","journal-title":"Autophagy"},{"issue":"2","key":"5006_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.298","volume":"41","author":"RA Irizarry","year":"2009","unstructured":"Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M et al (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41(2):178\u2013186","journal-title":"Nat Genet"},{"key":"5006_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019505","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA (2016) Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a019505","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"5006_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7555\/JBR.31.20160124","volume":"32","author":"A Sulaiman","year":"2018","unstructured":"Sulaiman A, Yao ZM, Wang LS (2018) Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression. J Biomed Res 32(2):81\u201390","journal-title":"J Biomed Res"},{"issue":"1","key":"5006_CR41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1091\/mbc.e08-04-0356","volume":"20","author":"JL Klessner","year":"2009","unstructured":"Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ (2009) EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell 20(1):328\u2013337","journal-title":"Mol Biol Cell"},{"issue":"10","key":"5006_CR42","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/ijc.23797","volume":"123","author":"ST Kundu","year":"2008","unstructured":"Kundu ST, Gosavi P, Khapare N, Patel R, Hosing AS, Maru GB, Ingle A, Decaprio JA, Dalal SN (2008) Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. Int J Cancer 123(10):2303\u20132314","journal-title":"Int J Cancer"},{"key":"5006_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/1471-2407-8-373","volume":"8","author":"VC Ramani","year":"2008","unstructured":"Ramani VC, Hennings L, Haun RS (2008) Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 8:373","journal-title":"BMC Cancer"},{"issue":"2","key":"5006_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.1821","volume":"207","author":"K Biedermann","year":"2005","unstructured":"Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, Hofler H, Keller G (2005) Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 207(2):199\u2013206","journal-title":"J Pathol"},{"issue":"8","key":"5006_CR45","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1096\/fj.201601138RR","volume":"31","author":"AM Overmiller","year":"2017","unstructured":"Overmiller AM, Pierluissi JA, Wermuth PJ, Sauma S, Martinez-Outschoorn U, Tuluc M, Luginbuhl A, Curry J, Harshyne LA, Wahl JR et al (2017) Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. FASEB J 31(8):3412\u20133424","journal-title":"FASEB J"},{"issue":"3","key":"5006_CR46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.prp.2014.10.008","volume":"211","author":"F Saaber","year":"2015","unstructured":"Saaber F, Chen Y, Cui T, Yang L, Mireskandari M, Petersen I (2015) Expression of desmogleins 1\u20133 and their clinical impacts on human lung cancer. Pathol Res Pract 211(3):208\u2013213","journal-title":"Pathol Res Pract"},{"issue":"36","key":"5006_CR47","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1038\/onc.2013.442","volume":"33","author":"R Kamekura","year":"2014","unstructured":"Kamekura R, Kolegraff KN, Nava P, Hilgarth RS, Feng M, Parkos CA, Nusrat A (2014) Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling. Oncogene 33(36):4531\u20134536","journal-title":"Oncogene"},{"issue":"Pt 10","key":"5006_CR48","first-page":"2339","volume":"127","author":"M Lowndes","year":"2014","unstructured":"Lowndes M, Rakshit S, Shafraz O, Borghi N, Harmon RM, Green KJ, Sivasankar S, Nelson WJ (2014) Different roles of cadherins in the assembly and structural integrity of the desmosome complex. J Cell Sci 127(Pt 10):2339\u20132350","journal-title":"J Cell Sci"},{"issue":"5","key":"5006_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrc3051","volume":"11","author":"RL Dusek","year":"2011","unstructured":"Dusek RL, Attardi LD (2011) Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer 11(5):317\u2013323","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5006_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12876-020-01588-2","volume":"21","author":"T Yang","year":"2021","unstructured":"Yang T, Gu X, Jia L, Guo J, Tang Q, Zhu J, Zhao W, Feng Z (2021) Dsg2 expression is low in colon cancer and correlates with poor survival. BMC Gastroenterol 21(1):7","journal-title":"BMC Gastroenterol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-05006-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:01:58Z","timestamp":1760979718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-05006-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-05006-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents for the use of their tissue samples in scientific research were obtained from all participants. This study obtained permission from the Research Ethics Committee of Inner Mongolia People\u2019s Hospital (202400901L).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}